Table 2.
Kaplan-Meier disease outcomes.
| Local control | Distant control | Progression-free Survival | Overall survival | |
|---|---|---|---|---|
| All patients | ||||
| 1 year | 73.5% | 85.0% | 64.8% | 96.3% |
| 2 year | 59.3% | 78.8% | 50.5% | 79.6% |
| CRT | ||||
| 1 year | 75.8% | 95.0% | 75.8% | *100% |
| 2 year | 52.7% | 90.0% | 54.2% | *94.1% |
| Non-CRT | ||||
| 1 year | 71.9% | 78.6% | 58.0% | *94.0% |
| 2 year | 63.8% | 72.0% | 48.0% | *71.6% |
| CRT subset who received surgery | ||||
| 1 year | 85.7% | 100% | 85.7% | 100% |
| 2 year | 68.6% | 100% | 68.6% | 100% |
Abbreviations; CRT, concurrent paclitaxel chemoradiotherapy cohort; Non-CRT, other treatment modalities cohort
*
Disease outcomes for CRT and Non-CRT cohort compared using log rank statistical test. p = 0.033 for overall survival, all other outcomes not statistically significant.